
Montelukast (10mg) + Levocetirizine (5mg)
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Monzem LC Tablet is a combined antihistamine and leukotriene receptor antagonist, comprising levocetirizine 5mg and montelukast 10mg per tablet. This medication is indicated for the relief of symptoms associated with allergic rhinitis, including perennial and seasonal patterns, and for the prevention of exercise-induced bronchospasm. Levocetirizine, an antihistamine, exhibits potent and selective H1-receptor antagonist properties, effectively alleviating symptoms such as sneezing, runny nose, itchy and watery eyes, and hives. Montelukast, a leukotriene receptor antagonist, inhibits the actions of cysteinyl leukotrienes, which are potent mediators of inflammation and constriction in the airways, thereby preventing bronchospasm and airway constriction. Monzem LC Tablet is administered orally once daily and is contraindicated in patients with hypersensitivity to any component of the tablet. The most common adverse effects include headache, nasopharyngitis, and sinusitis.
How to use Monzem LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monzem LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Monzem LC Tablet. Please consult your doctor.
High Risk
Monzem LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Monzem LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Monzem LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Monzem LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Monzem LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Monzem LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Monzem LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monzem LC Tablet may be needed. Please consult your doctor. Use of Monzem LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Monzem LC Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Monzem LC Tablet is a combined antihistamine and leukotriene receptor antagonist, comprising levocetirizine 5mg and montelukast 10mg per tablet. This medication is indicated for the relief of symptoms associated with allergic rhinitis, including perennial and seasonal patterns, and for the prevention of exercise-induced bronchospasm. Levocetirizine, an antihistamine, exhibits potent and selective H1-receptor antagonist properties, effectively alleviating symptoms such as sneezing, runny nose, itchy and watery eyes, and hives. Montelukast, a leukotriene receptor antagonist, inhibits the actions of cysteinyl leukotrienes, which are potent mediators of inflammation and constriction in the airways, thereby preventing bronchospasm and airway constriction. Monzem LC Tablet is administered orally once daily and is contraindicated in patients with hypersensitivity to any component of the tablet. The most common adverse effects include headache, nasopharyngitis, and sinusitis.
How to use Monzem LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monzem LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Monzem LC Tablet. Please consult your doctor.
High Risk
Monzem LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Monzem LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Monzem LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Monzem LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Monzem LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Monzem LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Monzem LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monzem LC Tablet may be needed. Please consult your doctor. Use of Monzem LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Monzem LC Tablet















